Skip to main content
. 2019 Jun 20;36(8):1922–1935. doi: 10.1007/s12325-019-01003-7

Table 1.

Patient characteristics

Characteristic R/R total (N = 707) R/R with HSCT (n = 476) R/R without HSCT (n = 231)
Age, mean years (SD) 52.0 (12.5) 51.2 (11.6) 53.6 (13.9)
Sex, n (%) male 377 (53.3) 258 (54.2) 119 (51.5)
Geographic region, n (%)
 Northeast 175 (24.8) 123 (25.8) 52 (22.5)
 Midwest 211 (29.8) 149 (31.3) 62 (26.8)
 South 264 (37.3) 170 (35.7) 94 (40.7)
 West 57 (8.1) 34 (7.1) 23 (10.0)
Payer type, n (%)
 Commercial 440 (62.2) 300 (63.0) 140 (60.6)
 Self-insured 245 (34.7) 167 (35.1) 78 (33.8)
 Medicare risk 5 (0.7) 1 (0.2) 4 (1.7)
 Medicaid 11 (1.6) 5 (1.1) 6 (2.6)
 Unknown 6 (0.8) 3 (0.6) 3 (1.3)
Charlson Comorbidity Index (CCI), mean (SD) 0.9 (1.4) 0.9 (1.3) 1.1 (1.5)
Baseline comorbid conditions, n (%)
 Asthma 36 (5.1) 24 (5.0) 12 (5.2)
 Cardiac arrhythmia 46 (6.5) 27 (5.7) 19 (8.2)
 Chronic pain/fibromyalgia 40 (5.7) 23 (4.8) 17 (7.4)
 Depression 39 (5.5) 25 (5.3) 14 (6.1)
 Diabetes 78 (11.0) 47 (9.9) 31 (13.4)
 Dyslipidemia 201 (28.4) 142 (29.8) 59 (25.5)
 Hypertension 218 (30.8) 137 (28.8) 81 (35.1)
 Liver/gallbladder/pancreatic disease 36 (5.1) 22 (4.6) 14 (6.1)
 Myocardial infarction/CAD 51 (7.2) 27 (5.7) 24 (10.4)
 Osteoarthritis 161 (22.8) 110 (23.1) 51 (22.1)
 Sleep disorders 47 (6.6) 37 (7.8) 10 (4.3)
 Smoking or history of smoking 61 (8.6) 36 (7.6) 25 (10.8)
 Thyroid disease 50 (7.1) 34 (7.1) 16 (6.9)

CAD coronary artery disease, HSCT hematopoietic stem cell transplantation, R/R relapsed/refractory